Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Ribonucleotide reductase R2 specific phosphorothioate oligonucleotide

EU orphan designation number: EU/3/08/542   
Active ingredient: Ribonucleotide reductase R2 specific phosphorothioate oligonucleotide
Indication: Treatment of acute myeloid leukaemia
Sponsor: Dr Ulrich Granzer
Mauerkircherstrasse 105, 81925 München, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/05/2008 Orphan designation EMEA/OD/118/07 (2008)1884 of 08/05/2008
28/05/2015 Change of name and/or address of sponsor